{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260602800286/en/Camizestrant-Combination-Delayed-Time-to-First-Progression-by-55-and-to-Second-Progression-by-37-in-Patients-With-Advanced-HR-positive-Breast-Cancer-With-an-Emergent-ESR1-Tumor-Mutation-in-SERENA-6-Trial", "message": "News view counter 773206 successfully enlarged"}